1700P - Safe switch of treatment from the reference product to RGB-02, a proposed biosimilar pegfilgrastim: Analysis of the results of three clinical trials
| Autor: | Illes, A. 1, Perjesi, L. 1, Horvat-Karajz, K. 1, Jeszenoi, N. 1, Aradi, I. 1, Singh, N.K. 2, Mair, S.J. 2, Kahan, Z. 3 |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|